Vimarsana
Biggest News Aggregation in the World

Page 2 - Integrated Data Analysis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Integrated Data Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Integrated Data Analysis Today - Breaking & Trending Today

FDA removal of decongestants made with ineffective drug would disrupt drug supply chain, experts say - Vimarsana News

FDA removal of decongestants made with ineffective drug would disrupt drug supply chain, experts say

In the event of administrative removal of these products, clinicians and consumers could substitute oral pseudoephedrine or intranasal decongestants such as phenylephrine or oxymetazoline, the authors say.

Source: umn.edu
Korea launches higher-accuracy AI-based voice analysis model to tackle voice scams - Vimarsana News

Korea launches higher-accuracy AI-based voice analysis model to tackle voice scams

The government has launched a higher-accuracy voice analysis model aimed at curbing rampant voice phishing scams and other voice-based crimes and plans to share the technology with foreign investigative bodies, a senior interior ministry official said Thursday.

S. Korea launches higher-accuracy AI-based voice analysis model to tackle voice scams - Vimarsana News

S. Korea launches higher-accuracy AI-based voice analysis model to tackle voice scams

The government has launched a higher-accuracy voice analysis model aimed at curbing rampant voice phishing scams and other voice-based crimes and plans to share the technology with foreign investigative bodies, a senior interior ministry official said Thursday. South Korea sees more than 20,000 cases of voice phishing scams every year, wrecking damage worth about 700 billion won (US$537.6 million). A total of more th...

Developing Countries Gain More Access to Cardiovascular Meds - Vimarsana News

Developing Countries Gain More Access to Cardiovascular Meds

email article The last decade saw middle-income countries enjoying improved access to cardiovascular medications, but they remain far from closing the considerable gap with richer countries. Cardiovascular drug sales grew about 10 times faster from 2008 to 2018 in middle-income countries than in high-income countries (annual growth rate 9.96% vs 0.98%), according to a large pharmaceutical sales database probed by Esther Chan, PhD, of the University of Hong Kong, and colleagues. As a result, the 15-fold gap in total cardiovascular medicine sales between the two country types in 2008 (27....